Literature DB >> 29297490

Prostate cancer: diagnostic criteria and role of immunohistochemistry.

Cristina Magi-Galluzzi1,2.   

Abstract

The diagnosis of prostate cancer is based on microscopic criteria. Presently, prostate needle biopsy interpretation can be a challenge for the pathologist due to the increased number of specimens with limited amount of suspicious glands and minimal atypia. It is critical for the pathologist to have an organized methodical approach when considering the morphological features enabling a definitive diagnosis of prostate cancer. Although several diagnostic criteria and supportive features have been advocated, only few findings are absolutely specific and diagnostic of prostate cancer. The diagnosis of prostate cancer relies on a combination of architectural and cytological features that are reviewed in detail herein. Infiltrative growth pattern, prominent nucleoli and lack of basal cells are the most useful diagnostic criteria. Perineural invasion, glomerulation and mucinous fibroplasia are pathognomonic features of prostate cancer, although uncommon on small prostate cancer foci. The role of immunohistochemistry in establishing a diagnosis of limited prostate is addressed.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29297490     DOI: 10.1038/modpathol.2017.139

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  7 in total

1.  Multi-resolution open-top light-sheet microscopy to enable efficient 3D pathology workflows.

Authors:  Lindsey A Barner; Adam K Glaser; Hongyi Huang; Lawrence D True; Jonathan T C Liu
Journal:  Biomed Opt Express       Date:  2020-10-22       Impact factor: 3.732

2.  Ex vivo fluorescence confocal microscopy: prostatic and periprostatic tissues atlas and evaluation of the learning curve.

Authors:  Laura Bertoni; Stefano Puliatti; Luca Reggiani Bonetti; Antonino Maiorana; Ahmed Eissa; Paola Azzoni; Luigi Bevilacqua; Valentina Spandri; Shaniko Kaleci; Ahmed Zoeir; Maria Chiara Sighinolfi; Salvatore Micali; Giampaolo Bianchi; Giovanni Pellacani; Bernardo Rocco; Rodolfo Montironi
Journal:  Virchows Arch       Date:  2020-01-06       Impact factor: 4.064

3.  Feasibility study for ex vivo fluorescence confocal microscopy (FCM) on diagnostic prostate biopsies.

Authors:  Ulf Titze; Torsten Hansen; Barbara Titze; Birte Schulz; Alfons Gunnemann; Bernardo Rocco; Karl-Dietrich Sievert
Journal:  Quant Imaging Med Surg       Date:  2021-04

4.  Normal Basal Epithelial Cells Stimulate the Migration and Invasion of Prostate Cancer Cell RM-1 by TGF-β1/STAT3 Axis in vitro.

Authors:  Chun-Yan Li; Chun-Ya Chen; Jian-Hong An; Jian-Bin Wu; Hong Shen
Journal:  Cancer Manag Res       Date:  2021-05-07       Impact factor: 3.989

5.  Transmembrane and Tetratricopeptide Repeat Containing 4 Is a Novel Diagnostic Marker for Prostate Cancer with High Specificity and Sensitivity.

Authors:  Rania Makboul; Islam F Abdelkawi; Dalia M Badary; Mahmoud R A Hussein; Johng S Rhim; Eman A Toraih; Mourad Zerfaoui; Zakaria Y Abd Elmageed
Journal:  Cells       Date:  2021-04-27       Impact factor: 6.600

Review 6.  Applications of scaffold-based advanced materials in biomedical sensing.

Authors:  Roya Sarkhosh-Inanlou; Vahid Shafiei-Irannejad; Sajjad Azizi; Abolghasem Jouyban; Jafar Ezzati-Nazhad Dolatabadi; Ahmad Mobed; Bashir Adel; Jafar Soleymani; Michael R Hamblin
Journal:  Trends Analyt Chem       Date:  2021-05-21       Impact factor: 14.908

7.  Concanavalin A-conjugated gold nanoparticle/silica quantum dot (AuNPs/SiQDs-Con A)-based platform as a fluorescent nanoprobe for the bioimaging of glycan-positive cancer cells.

Authors:  Somayeh Jafarzadeh; Nasrin Bargahi; Hassan Bagherpour Shamloo; Jafar Soleymani
Journal:  RSC Adv       Date:  2022-03-17       Impact factor: 3.361

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.